Randomised double-blind placebo-controlled trial of intravenous antioxidant therapy in predicted severe pancreatitis
Completed
- Conditions
- PancreatitisDigestive SystemAcute pancreatitis
- Registration Number
- ISRCTN56033334
- Lead Sponsor
- Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 225
Inclusion Criteria
In total 150 patients with predicted severe acute pancreatitis and approx 75 controls will be recruited over the four centres. Approximately 30 patients at SMUHT.
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in multiple organ dysfunction score.
- Secondary Outcome Measures
Name Time Method ot provided at time of registration